Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CG | P48736 | 1/20 | 0.45 |
| ▸ | NPC1 | O15118 | 2/20 | 0.37 |
| ▸ | RAB9A | P51151 | 2/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.37 |
| ▸ | USP2 | O75604 | 1/20 | 0.37 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.37 |
| ▸ | AAK1 | Q2M2I8 | 3/20 | 0.37 |
| ▸ | MTOR | P42345 | 6/20 | 0.37 |
| ▸ | LCK | P06239 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 3/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | RICTOR | Q6R327 | 3/20 | 0.33 |
| ▸ | RPTOR | Q8N122 | 3/20 | 0.33 |
| ▸ | MAPKAP1 | Q9BPZ7 | 3/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14292518 | 0.84 | PIK3CG (0.49) | PIK3CGNPC1RAB9ASMN1; SMN2USP2 | |
| SCHEMBL13486442 | 0.81 | PIK3CG (0.51) | PIK3CGNPC1RAB9ASMN1; SMN2USP2 | |
| SCHEMBL253529 | 0.76 | PIK3CG (0.56) | PIK3CGNPC1RAB9ASMN1; SMN2USP2 | |
| SCHEMBL9895355 | 0.75 | PIK3CG (0.45) | PIK3CGNPC1RAB9ASMN1; SMN2USP2 | |
| SCHEMBL9380420 | 0.72 | PIK3CG (0.56) | PIK3CGNPC1RAB9ASMN1; SMN2USP2 | |
| Hydrochloric Acid SCHEMBL9374890 | 0.71 | PIK3CG (0.59) | PIK3CGNPC1RAB9ASMN1; SMN2USP2 | |
| SCHEMBL28603278 | 0.70 | PIK3CG (0.46) | PIK3CGNPC1RAB9ASMN1; SMN2USP2 | |
| SCHEMBL12921179 | 0.69 | PIK3CG (0.56) | PIK3CGNPC1RAB9ASMN1; SMN2USP2 | |
| SCHEMBL13765046 | 0.69 | MAPT (0.51) | PIK3CGNPC1RAB9ASMN1; SMN2MTOR | |
| SCHEMBL13486444 | 0.69 | MAPT (0.51) | PIK3CGNPC1RAB9ASMN1; SMN2AAK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7589067-B2 | 6, 11-bridged tricyclic macrolides | ENANTA PHARMACEUTICALS, INC. (US) | 2009-09-15 | — | — | US | disclosed |
| US-20080039406-A1 | 3,6-BRIDGED TYLOSIN DERIVATIVES | ENANTA PHARMACEUTICALS, INC. | 2008-02-14 | — | — | US | disclosed |
| US-20080039406-A1 | 3,6-BRIDGED TYLOSIN DERIVATIVES | ENANTA PHARMACEUTICALS, INC. | 2008-02-14 | — | — | US | disclosed |
| US-20070082853-A1 | 6, 11-bridged tricyclic macrolides | ENANTA PHARMACEUTICAL, INC. | 2007-04-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070082853-A1 | 6, 11-bridged tricyclic macrolides | CYP2B6, CYP2D6, ABCB11 | PIK3CG 1838/4885NPC1 53/4885RAB9A 1907/4885 |
| US-20080039406-A1 | 3,6-BRIDGED TYLOSIN DERIVATIVES | ABCB11, ABCB1, CYP2B6 | PIK3CG 1551/4885NPC1 91/4885RAB9A 3390/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.